Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 2, 2009, Pages 101-106

  Li, Xiang ^a   Liu, Cheng ^a   Cui, Jian ^a   Dong, Min ^a   Peng, Cheng Hai ^a   Li, Qing Song ^a   Cheng, Jia Li ^a   Jiang, Shu Lin ^a   Tian, Ye ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD86 ANTIGEN; CYTOKINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSE COMPARISON; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD86; CHOLESTEROL, LDL; CORONARY DISEASE; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNITY, INNATE; MALE; MIDDLE AGED; PRAVASTATIN;

EID: 58449118699     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00340.x     Document Type: Article

References (20)

1. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008 199 : 3 11.
2. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999 138 : 419 20.
3. Hansson GK. Regulation of immune mechanisms in atherosclerosis. Ann N Y Acad Sci 2001 947 : 157 65.
4. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002 91 : 281 91.
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
6. Bobryshev YV, Lord RS. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res 1995 29 : 689 96.
7. Ozmen J, Bobryshev YV, Lord RS, Ashwell KW. Identification of dendritic cells in atherosclerotic lesion in rat with diet-induced hypercholesterolaemia. Histol Histopathol 2002 17 : 223 37.
8. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C et al. Emergence of dendritic cells in rupture prone regions of vulnerable carotid plaques. Atherosclerosis Sep 2004 176 : 101 10.
9. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the Establish Study. Circulation 2004 110 : 1061 8.
10. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004 291 : 1071 80.
11. Tziakas DN, Chalikias GK, Stakos DA, Papanas N, Chatzikyriakou SV, Mitrousi K et al. Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation. Am J Cardiol 2008 101 : 199 202.
12. Ranjit S, Dazhu L, Qiutang Z, Yibo F, Yushu L, Xiang W et al. Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina. Int J Cardiol 2004 97 : 551 5.
13. Türk U, Aliòlu E, Tengiz I, Ercan E, Mahmudov R, Duygu H et al. Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease. Anadolu Kardiyol Derg 2008 8 : 99 103.
14. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M et al. Markers of inflammation and cardiovascular disease. Application to Clinical and Public Health Practice: a statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
15. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A et al. Elevated levels of C-reactive protein at discharge in patents with unstable angina predict recurrent instability. Circulation 1999 99 : 855 60.
16. Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann NY Acad Sci 2003 987 : 15 25.
17. Steinman RM, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999 93 : 1634 42.
18. + monocytes. Arteriosclerosis Thrombosis and Vascular Biology 2005 25 : 1439.
19. Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006 189 : 408 13.
20. Földes G, von Haehling S, Okonko DO, Jankowska EA, Poole-Wilson PA, Anker SD. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. Int J Cardiol 2008 124 : 80 5.